Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows a new Revision: v3.5.4 tag replacing the previous v3.5.3, indicating a minor update to the document version. This reflects metadata refresh rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-18T04:01:05.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Taiwan site listing changes from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. This clarifies the city designation in the Locations list, aiding accurate site identification and search filters.
    Difference
    0.0%
    Check dated 2026-05-03T14:01:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site/version update rather than a change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-26T08:10:15.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a version bump with no changes to study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-04-19T01:30:28.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    - Adds hepatocellular carcinoma as a topic on the page. Introduces a Genetic and Rare Diseases Information Center resource and updates the revision to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:45:15.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3; no study content or page functionality were altered.
    Difference
    0.0%
    Check dated 2026-03-06T19:27:02.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.